Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

M&A

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • M&A

News Corp Subsidiary HarperCollins Focus Acquires Cider Mill Press Book Publishers; No Terms Disclosed

By Benzinga Newsdesk
October 3, 11:08 AM
NASHVILLE, Tenn., Oct. 3, 2022 /PRNewswire/ -- HarperCollins Focus today announced its acquisition of Cider Mill Press Book Publishers, an independent publisher of quality, high-design, gift

NWS

Read More
4 minute read
  • M&A

Ligand Announces Record Date And Details For Distribution For OmniAb Spin-Off

By Benzinga Newsdesk
October 3, 9:38 AM
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its board of directors has set October 26, 2022 as the record date (Record Date) for the dividend of shares of common stock of OmniAb, Inc. to

AHPA

Read More
1 minute read
  • M&A
  • News

Complete Solaria To Publicly List On NYSE Through Business Combination With Freedom Acquisition I Corp. Under Ticker ‘CLSR’

By Benzinga Newsdesk
October 3, 9:10 AM
Complete Solaria has entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE:FACT) ("Freedom"). Upon closing of the business combination, which is expected in the first

FACT

Read More
4 minute read
  • Biotech
  • Commodities
  • General
  • Health Care
  • Large Cap
  • M&A
  • Markets
  • Media
  • News
  • Tech

Google Now Shuts Down Translate App In China, Moderna-China COVID-19 Sales Talk Collapse, Disney-Dish Temporary Accord Ends Weekend Blackout: Top Stories Monday, Oct. 03

By Vandana Singh
October 3, 9:02 AM
Wall Street Journal

AMZN

Read More
1 minute read
  • M&A
  • Movers
  • Penny Stocks
  • Trading Ideas

Why LogicBio Therapeutics Stock Is Soaring Today

By Adam Eckert
October 3, 8:39 AM
LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share. 

AZN

Read More
1 minute read
  • M&A

HEICO Acquires TRAD SAS; Terms Not Disclosed

By Benzinga Newsdesk
October 3, 8:33 AM
HEICO Corporation today announced that its 3D PLUS subsidiary acquired TRAD SAS ("TRAD") for all cash consideration paid at closing. 3D PLUS is part of HEICO's Electronic Technologies Group. Further

HEI

Read More
1 minute read
  • M&A
  • News

Con Edison Divests Clean Energy Businesses To RWE For $6.8B

By Shivani Kumaresan
October 3, 8:11 AM
Consolidated Edison Inc (NYSE:ED) has entered into a purchase and sale agreement to sell its clean energy business and its subsidiaries…

ED

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Are LogicBio Therapeutics Shares Skyrocketing Today?

By Vandana Singh
October 3, 7:21 AM
AstraZeneca Plc’s (NASDAQ:AZN) subsidiary, Alexion, has agreed to acquire LogicBio Therapeutics Inc (NASDAQ:LOGC) for $2.07 per share. Both boards have unanimously approved…

AZN

Read More
1 minute read
  • Asset Sales
  • M&A
  • News

L3Harris Near Deal to Buy Part of Viasat’s Government-Systems Unit for ~$2B, The Wall Street Journal Reported Sunday

By Charles Gross
October 3, 5:16 AM
https://www.wsj.com/articles/defense-contractor-l3harris-near-deal-to-buy-part-of-viasat-s-government-systems-unit-sources-say-11664759276

LHX

Read More
6 minute read
  • M&A
  • News

Elon Musk Texts Revealed For Twitter Lawsuit: Exchanges With Joe Rogan, Gayle King, Jack Dorsey And More

By Chris Katje
October 2, 3:59 PM
As part of the ongoing saga that is Twitter Inc (NYSE: TWTR) versus Tesla Inc (NASDAQ: TSLA) CEO Elon Musk, text messages from the CEO’s phone were recently publicly released.

META

Posts pagination

Previous 1 … 392 393 394 … 448 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service